CD8A and neoplasm: The immune cells that process and present tumor antigens, such as DCs, and the cells killing tumors, such as NK cells, CD4+ T cells, and CD8+ T cells, were all significantly increased in the spleens of ME49Δgra5-vaccinated mice.